2012-11-20 19:26:35 -
Drugs and Treatments for Autoimmune Diseases: Global Markets (Market Research Report) - a new market research report on companiesandmarkets.com
Rheumatoid arthritis is the single most common disease of the auto-immune system and is one of the most attractive therapy areas in the auto-immune pharmaceutical industry. Over the last decade, the introduction of biologics has propelled growth in the market and with unmet clinic need, the auto-immune industry is set for further growth.The market is is dominated by agents that inhibit TNF-alpha and these include Remicade, Humira and Enbrel, generating over $10 billion in revenues. Additional agents include MabThera, Orencia, Cimzia and Actemra (for RA).The global market for autoimmune treatments reached at $34 billion in 2010, it is expected to reach at $38.9 billion by 2011 and it will further grow to $55 billion by 2016 at a compounded annual
growth rate (CAGR) of 7.2%. The U.S is the largest market for autoimmune treatments and holds 43% share in the global market. It will sustain its position and will hold 44% market share in 2016. Europe remains the second largest market for autoimmune treatments and holds 27% share in the global market. It will sustain its position and will hold 28% market share in 2016.The global market for autoimmune therapeutics was estimated at more than $34 billion in 2010, with mid-single-digit growth through 2016. Different segments such as arthritis and psoriasis treatments are projected to grow at a faster rate than other treatments. The report will analyze the global markets by region and by disease, and then provide growth projections for each region and/or disease.Autoimmune diseases arise from an overactive immune response by the body against substances and tissues normally present in the body. An autoimmune reaction can be triggered by a foreign substance entering the body; an alteration of normal body substances through a virus, drug, sunlight, or radiation; a malfunctioning of cells that control antibody production within the body; and genetic predisposition.Autoimmune diseases afflict individuals with symptoms presented in the neurological, musculoskeletal, dermatological, and gastrointestinal areas of the body. Women are more likely to have autoimmune disorders than men, and research is ongoing to determine why these diseases target women of all ages.This report is designed to investigate the autoimmune market by disease and by treatment, with supporting tables and figures to illustrate projected growth. The report will include the U.S., Europe, Japan, and other countries such as China and India.This report offers forecasts by product segment, disease, and geographical region from 2011 through 2016, including supporting analyses for projections. This report is a valuable tool for anyone assessing the autoimmune market and attempting to devise a strategy for successful competition within it. It provides a thorough background on the structure of the autoimmune market and the chief challenges and opportunities it faces. It offers the information necessary for understanding the current market and for addressing the emerging one.&
Click for report details:
www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports
www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports
www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports
www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.
